U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT07445906) titled 'A Study of RG002C0106 Injection in Adult Participants With Normal Renal Function and Mild-to-Moderate Renal Impairment' on Feb. 11.
Brief Summary: This is a Phase I trial designed to evaluate the impact of renal impairment on the efficacy and safety of the drug by comparing pharmacokinetic (PK) parameters and pharmacodynamic (PD) markers after a single subcutaneous injection of RG002C0106 between trial participants with normal renal function and those with mild to moderate renal impairment.
Study Start Date: March 15
Study Type: INTERVENTIONAL
Condition:
Renal Impairments
IgA Nephropathy (IgAN)
Intervention:
DRUG: RG002C0106
...